Pulmonary thromboembolism (PTE) is the third most frequent cardiovascular disease, with an increasing prevalence over time. The stratification of these patients is paramount to decide their therapeutic approach, since there have been high mortality rates for certain subgroups. The European Society of Cardiology, in its latest guidelines (2019), classified the severity of PTE according to…
8° ProEducar Educational Meeting – Extracardiac Intervention
Watch again the “8° ProEducar Educational Meeting – Learning with the Experts”, on Extracardiac Interventions on our Youtube channel. What things will I learn if I watch this video? 04:03 | Pulmonary angioplasty in chronic thromboembolic disease. When and how to perform endovascular treatment? – Fabio Solano Souza (BRA) 37:54 | Venous Intervention I: Deep…
COVID-19 PE: Nontraditional Risk Factors?
Risk factors for pulmonary embolism (PE) among patients with the new coronavirus are different from those traditionally observed. A French study recently published in Eur Heart J showed those new risk factors, and also that the risk of PE is reduced by the use of anticoagulant agents, just like in patients with conventional risk factors.…
What to Do and What Not to Do in Case of PE According to the New European Guidelines
As a “friendly,” easy-to-read document, the new European guidelines on pulmonary embolism (PE) include an excellent summary chart with new and modified items (compared with the 2014 guidelines), and also some sort of final conclusion composed of crucial tips and contraindications that come in handy in case of emergency. Diagnosis stage In suspected high-risk PE,…